Host-directed therapy: tuberculosis vaccine development.
Therapeutic Immunology, F79, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Hälsovägen, SE-14186 Stockholm, Sweden.
Martin
M
Rao
Centre for Clinical Microbiology, Division of Infection and Immunity, University College London and UCL Hospitals NHS Foundation Trust, London, UK.
Alimuddin
A
Zumla
Therapeutic Immunology, F79, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Hälsovägen, SE-14186 Stockholm, Sweden; Center for Allogeneic Stem Cell Transplantation, Stockholm, Sweden. Electronic address: Markus.Maeurer@ki.se.
Markus
M
Maeurer
D005260:Female; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D008297:Male; D014376:Tuberculosis / Q000517:prevention & control*; D032581:Tuberculosis Vaccines / Q000008:administration & dosage*
D032581:Tuberculosis Vaccines